IBDEI2C5 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39601,1,3,0)
 ;;=3^Bell's Palsy
 ;;^UTILITY(U,$J,358.3,39601,1,4,0)
 ;;=4^G51.0
 ;;^UTILITY(U,$J,358.3,39601,2)
 ;;=^13238
 ;;^UTILITY(U,$J,358.3,39602,0)
 ;;=G51.3^^153^1927^10
 ;;^UTILITY(U,$J,358.3,39602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39602,1,3,0)
 ;;=3^Clonic Hemifacial Spasm
 ;;^UTILITY(U,$J,358.3,39602,1,4,0)
 ;;=4^G51.3
 ;;^UTILITY(U,$J,358.3,39602,2)
 ;;=^5003995
 ;;^UTILITY(U,$J,358.3,39603,0)
 ;;=G51.4^^153^1927^16
 ;;^UTILITY(U,$J,358.3,39603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39603,1,3,0)
 ;;=3^Facial Myokymia
 ;;^UTILITY(U,$J,358.3,39603,1,4,0)
 ;;=4^G51.4
 ;;^UTILITY(U,$J,358.3,39603,2)
 ;;=^5003996
 ;;^UTILITY(U,$J,358.3,39604,0)
 ;;=G51.8^^153^1927^17
 ;;^UTILITY(U,$J,358.3,39604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39604,1,3,0)
 ;;=3^Facial Nerve Disorders NEC
 ;;^UTILITY(U,$J,358.3,39604,1,4,0)
 ;;=4^G51.8
 ;;^UTILITY(U,$J,358.3,39604,2)
 ;;=^5003997
 ;;^UTILITY(U,$J,358.3,39605,0)
 ;;=H34.01^^153^1927^53
 ;;^UTILITY(U,$J,358.3,39605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39605,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Right Eye
 ;;^UTILITY(U,$J,358.3,39605,1,4,0)
 ;;=4^H34.01
 ;;^UTILITY(U,$J,358.3,39605,2)
 ;;=^5005553
 ;;^UTILITY(U,$J,358.3,39606,0)
 ;;=H34.02^^153^1927^52
 ;;^UTILITY(U,$J,358.3,39606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39606,1,3,0)
 ;;=3^Transient Retinal Artery Occlusion,Left Eye
 ;;^UTILITY(U,$J,358.3,39606,1,4,0)
 ;;=4^H34.02
 ;;^UTILITY(U,$J,358.3,39606,2)
 ;;=^5005554
 ;;^UTILITY(U,$J,358.3,39607,0)
 ;;=G45.3^^153^1927^3
 ;;^UTILITY(U,$J,358.3,39607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39607,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,39607,1,4,0)
 ;;=4^G45.3
 ;;^UTILITY(U,$J,358.3,39607,2)
 ;;=^304129
 ;;^UTILITY(U,$J,358.3,39608,0)
 ;;=H53.2^^153^1927^12
 ;;^UTILITY(U,$J,358.3,39608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39608,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,39608,1,4,0)
 ;;=4^H53.2
 ;;^UTILITY(U,$J,358.3,39608,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,39609,0)
 ;;=H47.11^^153^1927^37
 ;;^UTILITY(U,$J,358.3,39609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39609,1,3,0)
 ;;=3^Papilledema Associated w/ Increased Intracranial Pressure
 ;;^UTILITY(U,$J,358.3,39609,1,4,0)
 ;;=4^H47.11
 ;;^UTILITY(U,$J,358.3,39609,2)
 ;;=^269212
 ;;^UTILITY(U,$J,358.3,39610,0)
 ;;=H47.20^^153^1927^35
 ;;^UTILITY(U,$J,358.3,39610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39610,1,3,0)
 ;;=3^Optic Atrophy,Unspec
 ;;^UTILITY(U,$J,358.3,39610,1,4,0)
 ;;=4^H47.20
 ;;^UTILITY(U,$J,358.3,39610,2)
 ;;=^5006126
 ;;^UTILITY(U,$J,358.3,39611,0)
 ;;=H47.321^^153^1927^15
 ;;^UTILITY(U,$J,358.3,39611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39611,1,3,0)
 ;;=3^Drusen of Optic Disc,Right Eye
 ;;^UTILITY(U,$J,358.3,39611,1,4,0)
 ;;=4^H47.321
 ;;^UTILITY(U,$J,358.3,39611,2)
 ;;=^5006141
 ;;^UTILITY(U,$J,358.3,39612,0)
 ;;=H47.322^^153^1927^14
 ;;^UTILITY(U,$J,358.3,39612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39612,1,3,0)
 ;;=3^Drusen of Optic Disc,Left Eye
 ;;^UTILITY(U,$J,358.3,39612,1,4,0)
 ;;=4^H47.322
 ;;^UTILITY(U,$J,358.3,39612,2)
 ;;=^5006142
 ;;^UTILITY(U,$J,358.3,39613,0)
 ;;=H47.323^^153^1927^13
 ;;^UTILITY(U,$J,358.3,39613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39613,1,3,0)
 ;;=3^Drusen of Optic Disc,Bilateral
 ;;^UTILITY(U,$J,358.3,39613,1,4,0)
 ;;=4^H47.323
 ;;^UTILITY(U,$J,358.3,39613,2)
 ;;=^5006143
 ;;^UTILITY(U,$J,358.3,39614,0)
 ;;=H47.331^^153^1927^43
 ;;^UTILITY(U,$J,358.3,39614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39614,1,3,0)
 ;;=3^Pseudopapilledema of Optic Disc,Right Eye
